Sy Jennifer
SEC CIK 2023998 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AEON | AEON Biopharma, Inc. | PRINCIPAL ACCOUNTING Off | 1.50M | — | — | 2 | 2024-08-31 | 2026-02-17 |
Most active insiders at AEON, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LYNCH TIMOTHY P | 10% | $243.5K | — |
| 2 | Bancroft Robert E. | Pres, CEO, Dir | — | — |
| 3 | Sy Jennifer | PRINCIPAL ACCOUNTING Off | — | — |
| 4 | Wilson Alexander Blair | CLO, CSO, Corp Sec | — | — |
| 5 | Oh Chad | Chief MEDICAL Off | — | — |
| 6 | Forth Marc | Dir | — | — |
| 7 | Bencich John | CFO | — | — |
| 8 | Carter Eric G | Dir | — | — |
| 9 | FISCHER JOST | Dir | — | — |
| 10 | Thunen Shelley B | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-05 | 2026-02-17+ | AEON | AEON Biopharma, Inc. | Sy Jennifer | PRINCIPAL ACCOUNTING Off | A - Grant | $0.00 | +1.50M | 1.50M | +597,978% | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | AEON Biopharma, Inc. | Sy Jennifer | PRINCIPAL ACCOUNTING Off | A - Grant | $0.00 | +18.0K | 18.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations